The US Food and Drug Administration (FDA) has approved the oral therapy regorafenib (Stivarga, Bayer) for the treatment of metastatic colorectal cancer.
What are the maximum doses of potassium, calcium, phosphorus, and magnesium that can be taken orally without significant adverse effect and with maximum clinical effect?
Response from Jenny A. Van Amburgh, PharmD, CDE
Assistant Dean of Academic Affairs and Associate Clinical Professor, School of Pharmacy, Northeastern University; Director, Clinical Pharmacy Team and Residency Program Director, Harbor Health Services, Inc., Boston, Massachusetts
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
[Link to free full text Guideline Summary at National Clearinghouse]
美國藥檢局核准新藥Linaclotide膠囊 (145ug) 上市，應用在原發性慢性便秘，以及大腸急躁症 (IBS) 合併便秘症。
The US Food and Drug Administration (FDA) approved the drug linaclotide (Linzess, Ironwood Pharmaceuticals) today for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults.
The US Food and Drug Administration (FDA) today approved bosutinib (Bosulif, Pfizer) as a new treatment option for adult patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).